Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo
S Zeuzem, J M Schmidt, J Lee, B Ruster, W K Roth – 1 February 1996 – In about 30% to 40% of patients with chronic hepatitis C, treatment with recombinant interferon alfa (r‐IFNα) causes a decrease of serum aminotransferases and hepatitis C virus (HCV) RNA. The antiviral mechanism of interferon alfa (IFNα) in vivo is unknown. From serial measurements of serum HCV‐RNA concentrations following IFNα induced perturbation of the balance between virus production and clearance, we obtained kinetic information on the pretreatment steady‐state of HCV.